merck & co. news - Search

Copilot

Your everyday AI companion

About 1,360,000 results

News about Merck & Co.

bing.com/news
$Court revives more than 500 lawsuits over Fosamax femur fracture risk$
· 1d
Court revives more than 500 lawsuits over Fosamax femur fracture risk
A U.S. appeals court on Friday revived more than 500 lawsuits alleging that Merck & …
· 1d
Merck & Co. Inc. stock outperforms competitors despite losses on the day
MSN · 2d
Merck's Keytruda Obtains its First FDA Approval for Mesothelioma
Zacks.com on MSN · 3d
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
· 3d
Behind the Scenes of Merck & Co's Latest Options Trends
See all
Explore More News
Pembrolizumab
Keytruda
Food and Drug Administration
See more news
Feedback
Thanks!Tell us more
People also ask
What happened to Merck & Co?
Merck & Co., Inc. (NYSE:MRK) is constantly striving to innovate and expand into new avenues. Its new pneumococcal conjugate vaccine for adults just received approval from the FDA. The company also closed its acquisition of EyeBio, in an attempt to venture into the ophthalmology industry and invent a treatment for retinal conditions.
Merck & Co., Inc. (MRK): A Good Beginner Stock According to Analysts
msn.com
Is Merck (MRK) a good stock to buy?
Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future. Over the past month, shares of this pharmaceutical company have returned +2.3%, compared to the Zacks S&P 500 composite's +1.3% change.
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Nee…
msn.com
Is Merck stock underperforming the S&P 500?
Merck’s stock was flat premarket but has gained 8.6% in the year to date, underperforming the S&P 500 which has gained 18%. Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural mesothelioma, a rare cancer associated with asbestos.
Merck wins first FDA approval for Keytruda as a treatment for mesotheli…
msn.com
Does Merck have a competitive advantage?
Merck & Co., Inc.’s (NYSE:MRK) commitment to innovation is its competitive advantage. Earlier this year, the company launched a new vaccine for adult patients with pulmonary arterial hypertension. The vaccine was only approved by the FDA in March and reported $70 million in sales during the quarter.
Is Merck & Co. (MRK) the Best Blue Chip Stock To Invest In According t…
msn.com
Feedback
Merck
https://www.merck.com/media/news
News releases - Merck.com
WEB5 days ago · September 11, 2024. Merck Announces Positive Top-line Results from Phase 3 Trial Evaluating Efficacy and Safety of GARDASIL®9 in Japanese Males. September …
- Estimated Reading Time: 2 mins
Missing:
- merck & co.
Must include:
- merck & co.
- Merck Announces Fourth-…
  Initiated More Than 20 Phase 3 Study Starts, Including the Progression of …
- Merck to Acquire EyeBio - M…
  Merck to acquire EyeBio for a $1.3 billion upfront payment and up to $1.7 billion in …
See results only from merck.com
MarketWatch
https://www.marketwatch.com/story/mercks-wins-fda...
Merck wins first FDA approval for Keytruda as a treatment for ...
WEB4 days ago · Merck & Co. Inc. said Wednesday the U.S. Food and Drug Administration has approved its blockbuster cancer drug Keytruda as a treatment for malignant plural …
Merck
https://www.merck.com/news/merck-announces-fourth...
Merck Announces Fourth-Quarter and Full-Year 2023 Financial …
WEBFeb 1, 2024 · Initiated More Than 20 Phase 3 Study Starts, Including the Progression of Eight Novel Assets Into Phase 3 in 2023. Augmented Pipeline Through Acquisitions of …
CNBC
https://www.cnbc.com/2024/07/30/merck-mrk-earnings-q2-2024.html
Merck (MRK) earnings Q2 2024 - CNBC
WEBJul 30, 2024 · Merck on Tuesday reported second-quarter revenue and adjusted earnings that topped Wall Street’s expectations as it saw strong sales from its blockbuster cancer …
Merck
https://www.merck.com/news/merck-t…
Merck to Acquire EyeBio - Merck.com
WEBMay 29, 2024 · Merck to acquire EyeBio for a $1.3 billion upfront payment and up to $1.7 billion in future milestone payments for a potential value of $3 billion.
Tags:
Merck & Co.
Acquire
Merck
https://www.merckgroup.com/en/news/two-ai...
Merck Enters Two Strategic Collaborations to Strengthen AI-driven …
WEBSep 20, 2023 · Merck, a leading science and technology company, today announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial …
Tags:
Merck & Co.
Gangolf Schrimpf
Strategic management
Drug discovery
Merck
https://www.merckgroup.com/en/news-…
News & Stories - Merck
WEBSep 12, 2024 · Check out the latest Merck news and stories! Learn more about the leading science and technology company here.
Tags:
Merck & Co.
Stories
Yahoo Finance
https://finance.yahoo.com/news/merck-announces...
Merck Announces Fourth-Quarter and Full-Year 2023 Financial …
WEBFeb 1, 2024 · MRK. Fourth-Quarter and Full-Year Sales Reflect Sustained Growth Across Oncology and Vaccines. Fourth-Quarter Worldwide Sales Were $14.6 Billion, an …
Tags:
Merck & Co.
Finance
Yahoo Finance
https://finance.yahoo.com/quote/MRK/…
Merck & Co., Inc. (MRK) Latest Stock News & Headlines …
WEBGet the latest Merck & Co., Inc. (MRK) stock news and headlines to help you in your trading and investing decisions.
Tags:
Merck & Co.
Merck Stock Price Today
Mrk Stock News
Merck Co Inc Nyse Mrk
Reuters
https://www.reuters.com/business/healthc…
Merck raises 2024 profit forecast on surging sales of …
WEBApr 25, 2024 · Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of double-digit growth for its blockbuster cancer drug Keytruda, the world's top selling prescription medicine.
Tags:
Merck & Co.
Reuters
People also search for
merck pharmaceutical breaking news
merck & co recent news
merck rumors
merck announcement today
merck press release today
molnupiravir merck
Related searches for merck & co. news
Pagination
- 1
- 2
- 3
- 4
- Next